1 terminated, 1 withdrawn. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Terminated 1, Withdrawn 1 |
Follow Hyperactive Delirium: new trials by email Literature Review of Hyperactive Delirium trials Research Report on Hyperactive Delirium
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Valproate Alone or in Combination With Quetiapine for Severe COVID-19 Pneumonia With Agitated Delirium Valproate, Quetiapine, Standard of Care - Covid19, Hyperactive Delirium | Phase 4 | Withdrawn | University of Miami | 2023-03-28 | 2023-03-31 | |
| Valproic Acid for Treatment of Hyperactive or Mixed Delirium in ICU Valproic Acid, Placebo, Haloperidol - Hyperactive Delirium, Mixed Delirium | Phase 4 | Terminated | Stanford University | 3 | 2015-01-01 | 2019-06-26 |
COVID-19 (1) · Pneumonia, Viral (1)
Coronaviridae Infections (1) · Coronavirus Infections (1) · Infections (1) · Lung Diseases (1) · Nidovirales Infections (1) · Pneumonia (1) · RNA Virus Infections (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1) · Virus Diseases (1)
Valproic Acid (2) · Haloperidol (1) · Quetiapine Fumarate (1) · Standard of Care (1)
Stanford University (1) · University of Miami (1)
United States (1)
Dominique L Musselman, MD (1) · Jose R Maldonado, M.D. (1) · Yelizaveta Sher, M.D. (1)